Advancing Artificial Intelligence for Medicine and Genetics

Ronak Y. Patel is a scientist, innovator, and leader in genomics and bioinformatics with a proven track record of building impactful resources that advance precision medicine. With more than a decade of experience in academic research and leadership, he has transformed complex genetic and biomedical data into accessible, widely adopted tools for clinicians and researchers worldwide.

As an Assistant Professor at Baylor College of Medicine, Ronak led the development of several key platforms under the NIH-funded Clinical Genome (ClinGen) project, including the ClinGen Allele Registry, Pathogenicity Calculator, Evidence Repository, and Actionability Curation Interface. These resources—now used by thousands of clinicians and scientists globally—have solved long-standing challenges in genetic variant interpretation and data sharing. Notably, his contributions include two resources that became part of the first FDA-approved genetic variant database, a milestone in clinical genomics.

Earlier in his career, Ronak pioneered computational methods at Washington University in St. Louis and the University of Mississippi, applying bioinformatics, structural biology, and machine learning to advance drug discovery and transcription factor analysis. His research has been published in top-tier journals such as Science, Cell, Genome Medicine, and The American Journal of Human Genetics, with over 30 publications and significant citations reflecting his impact in the field. His work has also attracted attention from the FDA, NIH, and international genomic consortia, underscoring its global relevance.

An educator and mentor, Ronak has co-directed courses in bioinformatics and genome analysis, earning top ratings from students for his innovative teaching style. His entrepreneurial mindset has been evident throughout his career—whether in building tools adopted by global communities, creating licensing and revenue opportunities from bioinformatics platforms, or driving international collaborations in genomics.

As the founder of Nucleati, Ronak brings together deep scientific expertise, a passion for technology-driven solutions, and a vision to accelerate discovery and translation in healthcare. His mission is to bridge the gap between cutting-edge genomic science and real-world clinical applications, empowering researchers, clinicians, and patients alike.

Business Transformation Leader | Agile Strategist | Entrepreneurial Innovator

Shridhan is a seasoned business and technology leader with over two decades of experience driving transformation across IT, healthcare, life sciences, pharmaceuticals, banking, education, and retail. He bridges the gap between business strategy and technology execution, helping organizations unlock growth, efficiency, and innovation.

A Harvard Leadership Program graduate and dual MBA in Finance and Marketing, Shridhan has led enterprise-level Agile transformations at Millipore Sigma, building high-performing teams, coaching cross-functional leaders, and delivering high-impact eCommerce and B2B initiatives.

Earlier, he held key sales and marketing leadership roles at Abbott and Randox Laboratories, managing distributor networks, driving revenue growth, and executing market expansion strategies in competitive healthcare and diagnostic markets. As a business owner, Shridhan successfully founded and managed ventures, developing end-to-end operations, scaling teams, and delivering sustainable growth, demonstrating strong leadership, strategic vision, and entrepreneurial execution.

Shridhan combines a strategic mindset with hands-on execution, guiding organizations through multimillion-dollar product launches, business expansions, and digital transformations. Known for inspiring teams and fostering collaboration across global stakeholders, he brings discipline, vision, and entrepreneurial insight to every challenge.

Today, Shridhan continues to integrate business management, technology, and Agile leadership to help organizations innovate, adapt, and thrive in rapidly evolving markets.

Scientist | Bioanalyst | Biomarker Research Expert

Rohini Sidhu brings more than 15 years of specialized experience in bioanalysis and biomarker research. Currently, she contributes her expertise to Novo Nordisk, focusing on nonclinical and Phase 1 clinical studies. Her strong background in scientific project management and laboratory operations enhances her ability to drive successful outcomes in complex research environments.

Rohini's previous position at Washington University in St. Louis allowed her to significantly impact the field by developing diagnostic biomarkers and newborn screening tests for NPC1 disease.

Outside of her professional commitments, Rohini actively engages with the scientific community through consulting, sharing her knowledge and insights to promote advancements in the field. She has authored over 40 peer-reviewed articles, which highlight her dedication to research excellence and can be accessed via her Google Scholar profile: Rohini Sidhu - Google Scholar

Physician-Scientist | Pediatric Pathology Expert | Translational Research Advisor

Dr. Kalyani R. Patel, MD, FCAP is a globally recognized physician-scientist and academic leader with deep expertise in pediatric and anatomic pathology, digital health innovation, and translational research. With more than 15 years of experience across clinical practice, research, and medical informatics, she brings a unique perspective that bridges precision diagnostics, digital transformation, and healthcare innovation.

As an Associate Professor in the Division of Pathology and Immunology at Cincinnati Children’s Hospital, Dr. Patel leads initiatives that integrate advanced analytics, AI, and digital pathology into pediatric medicine. Previously, as Medical Director of Anatomic Pathology Informatics at Texas Children’s Hospital and Baylor College of Medicine, she spearheaded modernization efforts that redefined diagnostic workflows and quality assurance systems—pioneering data-driven pathology practices that improved both accuracy and efficiency.

Dr. Patel’s research has contributed to landmark advances in pediatric liver and lung pathology, including the identification of novel biomarkers and the development of precision approaches to rare childhood diseases. Her work has been featured in top scientific journals such as Science Translational Medicine, Nature, Journal of Hepatology, and Pediatric and Developmental Pathology. She has collaborated with leading scientists, clinicians, and data experts worldwide to translate discoveries from the lab to the clinic.

A frequent keynote speaker and mentor, Dr. Patel has presented at major international conferences on AI integration in diagnostic medicine, pathology informatics, and digital health transformation. Her leadership in developing web-based reporting tools and digital pathology platforms has influenced clinical practices across academic medical centers.

Dr. Patel has received multiple national honors, including the Gordon F. Vawter Award from the Society of Pediatric Pathology, and is widely respected for her ability to combine scientific depth with operational innovation. As an advisor, she brings a forward-thinking vision that aligns with Nucleati’s mission to accelerate genomics and healthcare innovation through technology, data, and translational science.